29 May 2026
: Case report
[In Press] Catheter-Directed Thrombolysis and Direct Oral Anticoagulant Class Switch to Prevent Pulmonary Embolism From Large Inferior Vena Cava Thrombus
Management of emergency care, Rare coexistence of disease or pathology
Takashi Araki1ABCDEF, Kazuyuki Nishimura1DEF, Yusuke Hitora1DEF, Kenichiro Yokoi1DEF, Takashi Yamada1DEF, Manabu Miura1DEFDOI: 10.12659/AJCR.953199
Am J Case Rep In Press; DOI: 10.12659/AJCR.953199
Available online: 2026-05-29, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Inferior vena cava (IVC) thrombosis is an uncommon complication of deep vein thrombosis and may be associated with a high risk of severe pulmonary embolism, particularly in the presence of free-floating thrombi. Although IVC filter placement may be considered to prevent embolization, prolonged filter dwell increases the risk of recurrent venous thrombosis and reduces retrieval success, highlighting the importance of early thrombus clearance. However, evidence regarding optimal interventional and anticoagulation strategies for IVC thrombosis remains limited.
CASE REPORT
A 46-year-old woman with Down syndrome and adjustment disorder presented with sudden-onset chest pain and syncope. On admission, she was hypotensive and hypoxemic. Contrast-enhanced computed tomography revealed bilateral pulmonary emboli and a large floating IVC thrombus extending from below the renal vein to the right common iliac vein. A retrievable IVC filter was placed, and anticoagulation was initiated. No underlying thrombophilia was identified. After 2 weeks, regression of the IVC thrombus was insufficient, and catheter-directed thrombolysis with alteplase and heparin was performed, resulting in marked clinical improvement. The patient was discharged on apixaban. After 2.5 months, the pulmonary arterial thrombi had resolved; however, the IVC thrombus persisted. Switching anticoagulation from apixaban to dabigatran led to complete thrombus resolution 4 months after symptom onset, allowing successful retrieval of the IVC filter.
CONCLUSIONS
This case highlights the potential role of alteplase-based catheter-directed thrombolysis for early thrombus reduction and suggests that switching from a factor Xa inhibitor to a direct thrombin inhibitor may be effective in select patients with refractory IVC thrombosis.
Keywords: Catheterization; Dabigatran; Direct Oral Anticoagulants; Inferior Vena Cava; Pulmonary Embolism; Thrombolytic Therapy; Tissue Plasminogen Activator
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






